Effect of Adaptive Servoventilation on Cardiac Function in Chronic Heart Failure and Cheyne-Stokes Respiration

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2010 by Military Institute of Medicine, Poland.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Military Institute of Medicine, Poland
ClinicalTrials.gov Identifier:
NCT01212705
First received: September 30, 2010
Last updated: NA
Last verified: September 2010
History: No changes posted
  Purpose

Sleep disordered breathing is common in patients with chronic heart failure. Adaptive servoventilation is a novel method of treatment central sleep apnoea, especially associated with Cheyne-Stokes-respiration. The aim of the study is to investigate effect of adaptive servoventilation on cardiac function, exercise tolerance and quality of life in patients with chronic heart failure.


Condition Intervention
Chronic Heart Failure
Central Sleep Apnea
Cheyne-Stokes Respiration
Device: Adaptive servoventilation

Study Type: Interventional
Official Title: Effect of Adaptive Servoventilation on Cardiac Function, Exercise Tolerance and Quality of Life in Patients With Chronic Heart Failure and Cheyne-Stokes Respiration

Resource links provided by NLM:


Further study details as provided by Military Institute of Medicine, Poland:

Arms Assigned Interventions
Experimental: ASV Device: Adaptive servoventilation
Background expiratory positive airway pressure with some inspiratory pressure support when needed

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • chronic heart failure with ejection fraction ≤45%
  • optimal medical treatment for at least 1 month
  • clinical diagnosis of Cheyne-Stokes respiration

Exclusion Criteria:

  • unstable heart failure
  • stroke
  • transient ischemic attack in last 6 months
  • pacemaker, cardioverter-defibrillator or resynchronization device implanted less than 6 months before study entrance
  • severe chronic obstructive pulmonary disease
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01212705

Contacts
Contact: Anna Kazimierczak 48 22 6818017 annakazimierczak@poczta.onet.pl
Contact: Krystian Krzyzanowski 48 512 356 207 krystian.krzyzanowski@gmail.com

Locations
Poland
Military Institute of Medicine Recruiting
Warsaw, Szaserow 128, Poland, 04-141
Sponsors and Collaborators
Military Institute of Medicine, Poland
Investigators
Principal Investigator: Anna Kazimierczak Military Institute of Medicine
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT01212705     History of Changes
Other Study ID Numbers: BW2126/10
Study First Received: September 30, 2010
Last Updated: September 30, 2010
Health Authority: Poland: Ministry of Health

Additional relevant MeSH terms:
Cheyne-Stokes Respiration
Heart Failure
Sleep Apnea Syndromes
Sleep Apnea, Central
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Signs and Symptoms
Heart Diseases
Cardiovascular Diseases
Apnea
Sleep Disorders, Intrinsic
Dyssomnias
Sleep Disorders
Nervous System Diseases

ClinicalTrials.gov processed this record on April 23, 2014